Skip to Main Content
Pharmacist's Letter Canada
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Natural Medicines Resources
  • CE & Training
    • CE Organizer
    • Available Courses
    • Live CE Calendar
    • Print Statements
    • Licenses
    • Additional Requirements
    • Exemptions
  • New Drugs
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Cardiology
  4. Antithrombotics
  5. Treatment

Treatment

  • Angina (14)
  • Antithrombotics (366)
    • Drug-Induced Thrombosis (32)
    • Prevention (38)
    • Reversal (15)
    • Treatment (335)
      • Apixaban (Eliquis) (86)
      • Aspirin (178)
      • Clopidogrel (Plavix) (116)
      • Dabigatran (Pradaxa) (113)
      • Edoxaban (Savaysa) (27)
      • Low Molecular Weight Heparins (66)
      • Other (53)
      • Prasugrel (Effient) (50)
      • Rivaroxaban (Xarelto) (111)
      • Ticagrelor (Brilinta) (32)
      • Vorapaxar (Zontivity) (1)
      • Warfarin - Drug Interactions (37)
      • Warfarin - Treatment (162)
  • Arrhythmias (174)
  • Blood Pressure (30)
  • Cardiovascular Disease and Depression (9)
  • Cholesterol (56)
  • Dyslipidemia (267)
  • Endocarditis (20)
  • Heart Disease (75)
  • Heart Failure (181)
  • Hypertension (301)
  • Hypotension (19)
  • Ischemic Heart Disease/Acute Coronary Syndromes (351)
  • Myocardial Infarction (41)
  • Peripheral Vascular Disease (9)
  • Raynaud's (1)
  • Resources (891)
  • Stroke (170)
316 - 330 of 335 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Commentary: Antiplatelet Agents for Stroke Prevention October 2008
Chart: Venous Thromboembolism (VTE) Treatment -- CHEST Update October 2008
Other: Please See Information from The Joint Commission Concerning Preventing Errors Related to Anticoagulation October 2008
Article: Pradax (dabigatran etexilate) to compete with warfarin and heparins August 2008
Article: what to do about aspirin, clopidogrel, NSAIDs, and warfarin when patients need surgery August 2008
Article: whether they should take TWO aspirin daily August 2008
Commentary: Managing Warfarin & Antiplatelet Drugs Perioperatively August 2008
Guideline: ACCP Antithrombotic and Thrombolytic Guidelines, 8th edition. Executive Summary August 2008
Article: big misconception that generics vary by as much as 20% from brand-name drugs July 2008
Article: glucosamine alone or with chondroitin can interact with warfarin June 2008
Commentary: Glucosamine/Chondroitin and Warfarin Interaction June 2008
Article: heparin recall rekindles concern over the safety of drugs made overseas May 2008
Article: a potential interaction between proton pump inhibitors and clopidogrel (Plavix) April 2008
Commentary: LMWH Dosing in Obesity February 2008
Article: whether fish oil supplements are safe August 2007
  • « Prev
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • News and Resources
  • Products
  • Individual Solutions
  • Enterprise Solutions
© Therapeutic Research Center. All Rights Reserved